Institute of Clinical and Molecular Virology

New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. (2015) Reiter C, Fröhlich T, Zeino M, Marschall M, Bahsi H, Leidenberger M, Friedrich O, et al. Journal article, Original article Impact of Adenovirus E4-ORF3 Oligomerization and Protein Localization on Cellular Gene Expression (2015) Vink EI, Zheng Y, Yeasmin R, Stamminger T, Krug LT, Hearing P Journal article Dynamic Angiography and Perfusion Imaging Using Flat Detector CT in the Angiography Suite: A Pilot Study in Patients with Acute Middle Cerebral Artery Occlusions (2015) Struffert T, Deuerling-Zheng Y, Kloska S, Engelhorn T, Lang S, Mennecke A, Manhart M, et al. Journal article No evidence for human papillomavirus infection in focal cortical dysplasia IIb (2015) Coras R, Korn K, Bien CG, Kalbhenn T, Roessler K, Kobow K, Giedl J, et al. Journal article Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assay (2015) Gruener N, Viazov S, Korn K, Knöll A, Trippler M, Schlaak JF, Gerken G, et al. Journal article Radiation dose in cerebral angiography and flat detector CT applications in neuroradiology (2015) Struffert T, Lang S, Scholz R, Hauer M, Dörfler A Journal article Controlled crystal dehydration triggers a space-group switch and shapes the tertiary structure of cytomegalovirus immediate-early 1 (IE1) protein (2015) Klingl S, Scherer M, Stamminger T, Muller Y Journal article, Original article Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA (2015) Herzner AM, Hagmann CA, Goldeck M, Wolter S, Kuebler K, Wittmann S, Gramberg T, et al. Journal article AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity (2015) Fuchs S, Martinez-Navio JM, Piatak M, Lifson JD, Gao G, Desrosiers RC Journal article Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis (2015) Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, et al. Journal article